InvestoGain

Investogain Pty Limited
AFS Licence No. 334036

All correspondence to:
admin@delisted.com.au
or by mail to:
PO Box 400
Crows Nest NSW 1585

26 April 2025

Name:	INNLANZ LIMITED (INL)
ISIN:	AU0000035362
Date of Listing:	22 February 2019
Date of Delisting:	05 August 2024
Former Names:

Stock Exchange Status: (updated daily)

This entity was delisted from the Australian Securities Exchange on 05 August 2024.

Legal Status: (updated monthly)

ACN: 628 420 824ABN: 83 628 420 824
Registration Date: 27 August 2018

To our knowledge this is a current registered entity, not in any form of external administration. If you have questions about your shareholding they may be taken up with us here: https://www.delisted.com.au/TraceLostSharesLostMoney/index/.

Capital Gains Tax (CGT) Status: (updated at least quarterly)

The securities in this entity, in our opinion, are of little or no value. We have made that assessment by reference to the circumstances leading to a suspension and/or delisting, the length of a suspension, share trading history and last on-market share price, most recent financial and cash flow statements, prospects (including likelihood of re-financing), and other factors including in particular whether the entity is in external administration. If you are seeking to crystallise a capital loss on your securities, that process can be easily and quickly initiated at our online Worthless Shares facility here: https://www.delisted.com.au/sell-worthless-and-other-securities/.

Updates, corrections, disagreements please email to admin@delisted.com.au

Further information: deListed and InvestoGain are operated by Investogain Pty Limited which is licensed by ASIC as an Australian Financial Services Licensee (AFSL 334036). deListed acquires only securities that it deems to be of little or no value, in circumstances where the holder is unable to sell their securities on-market in the normal manner. This service has been provided online via the company’s website www.delisted.com.au since 2004.

Getting advice: Information provided in this section is of a general nature and applicable only to Australian tax residents who hold their investments on capital account (ie for long-term investment purposes). It has been prepared without taking into account your financial needs or tax situation. Before acting on the information, deListed suggests that you consider whether it is appropriate for your circumstances and recommends that you seek independent legal, financial, or taxation advice.

Disclaimer: The information provided above is to the best of our knowledge accurate as of today. But you should bear in mind that it is of a general nature and does not constitute financial or tax advice. Investogain Pty Limited accepts no liability for any loss arising from reliance on this information, including reliance on information that is no longer current.

INNLANZ LIMITED(INL)

Click here for free access to this company's:
ASX, Legal & CGT Status

Former (or subsequent) names

	FROM	TO
MEDILAND PHARM LIMITED		16/12/2021

Shareholder links

Our website ranking of INL:

(2 out of 5)

REGISTRY:

6 Hope St Ermington NSW 2115

Tel : +61 (0)3 9415 4000 or 1300 850 505 (within Australia)
Fax : +61 2 8235 8150
RegistryWebsite RegistryEmail

Company details

ISIN: AU0000035362

Address: 18-40 Anderson Street Parramatta NSW 2150
Tel: (+6 12) 9689 9969 Fax:

Date first listed: 22/02/2019
Company Secretary:
Sector: Retailing Industry Group:
Activities: Operates retail outlets that service inbound Chinese visitors that come to Australia via organised tours arranged under the Approved Destination Status scheme

News & Events

Expand this box to read and print

The company has lodged financial reports with ASIC.	29/11/2024
Shareholders in this company should consider crystallising a capital loss in 2024/25 by selling their shares. This process is now much easier and quicker. It can be achieved online by entering transaction details here. While, this usually makes good economic sense we recommend you seek professional advice before buying or selling securities, your accountant is probably the best person.	13/09/2024
delisted at entity's request under Listing Rule 17.11	05/08/2024
we understand the company delisted because of the costs of the listing, low level of trading on ASX and the impact of small trades on the share price - prior to delisting the company offered $0.013 to buy shares in an off-market buy-back	05/08/2024
The company lodges its Quarterly Activities/Appendix 4C Cash Flow Report.	31/07/2024
The company releases a notification of cessation of securities.	31/07/2024
The securities of Innlanz Limited will be suspended from quotation at the close of trading today, Tuesday, 30 July 2024 under Listing Rule 17.2, at the request of INL, pending removal of INL from the official list of ASX Limited	30/07/2024
The suspension of trading in the securities of Innlanz Limited will be lifted from the commencement of trading today, Monday, 11 March 2024 following lodgement of its half year accounts for the period ended 31 December 2023.	11/03/2024
The company lodges its Half Year Accounts.	07/03/2024
The securities of the company will be suspended from quotation under Listing Rule 17.5 from the commencement of trading today, Friday, 1 March 2024, for not lodging the relevant periodic report by the due date. If the report is lodged between the closure of the market announcements office on Thursday, 29 February 2024, and the imposition of the suspension, the entity's securities will normally be reinstated to quotation on the next trading day after the suspension is imposed.	01/03/2024
name changed from Mediland Pharm Limited	16/12/2021

ASX Announcements (courtesy of ASX)

Click here for free access to this company's:
ASX, Legal & CGT Status

Your comments

Please read our Terms before viewing comments.

Company Updates

Post your comments here

Please read our Terms before posting comments.

Click here for free access to this company's:
ASX, Legal & CGT Status

Directors' on-market share transactions (last 5)

Purchases Sales

DATE	DIRECTOR	NUMBER	PRICE	AMOUNT
31/12/2019	Leo Cui	31,000	$0.275	$8,509.00
16/12/2019	Leo Cui	30,000	$0.275	$8,250.00

Click here for the last 20 transactions all companies

Directors & Executives (current)

NAME	TITLE	DATE OF APPT
Peter French	Non Exec Chairman	22/02/2019
Yesh Mudaliar	Managing Director	22/02/2019
Jessie Tao	CFO	22/02/2019
Theo Renard	Non Exec Director	26/01/2019
Leo Cui	Director	29/11/2019
Indira Naidu	Company Secretary

Date of first appointment, title may have changed.

Directors & Executives (former)

NAME	TITLE	DATE OF APPOINTMENT	DATE OF RESIGNATION

Date of first appointment, title may have changed.